These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 21085649)

  • 1. Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting.
    Suhre K; Meisinger C; Döring A; Altmaier E; Belcredi P; Gieger C; Chang D; Milburn MV; Gall WE; Weinberger KM; Mewes HW; Hrabé de Angelis M; Wichmann HE; Kronenberg F; Adamski J; Illig T
    PLoS One; 2010 Nov; 5(11):e13953. PubMed ID: 21085649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-targeted metabolomics combined with genetic analyses identifies bile acid synthesis and phospholipid metabolism as being associated with incident type 2 diabetes.
    Fall T; Salihovic S; Brandmaier S; Nowak C; Ganna A; Gustafsson S; Broeckling CD; Prenni JE; Kastenmüller G; Peters A; Magnusson PK; Wang-Sattler R; Giedraitis V; Berne C; Gieger C; Pedersen NL; Ingelsson E; Lind L
    Diabetologia; 2016 Oct; 59(10):2114-24. PubMed ID: 27406814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A metabolome-wide characterization of the diabetic phenotype in ZDF rats and its reversal by pioglitazone.
    Jönsson TJ; Schäfer HL; Herling AW; Brönstrup M
    PLoS One; 2018; 13(11):e0207210. PubMed ID: 30481177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of change in metabolome caused by comprehensive diabetes treatment: A prospective observational study of diabetes inpatients with gas chromatography/mass spectrometry-based non-target metabolomic analysis.
    Taya N; Katakami N; Omori K; Arakawa S; Hosoe S; Watanabe H; Takahara M; Miyashita K; Nishizawa H; Matsuoka TA; Furuno M; Bamba T; Iida J; Fukusaki E; Shimomura I
    J Diabetes Investig; 2021 Dec; 12(12):2232-2241. PubMed ID: 34032389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood Metabolomic Measures Associate With Present and Future Glycemic Control in Type 2 Diabetes.
    't Hart LM; Vogelzangs N; Mook-Kanamori DO; Brahimaj A; Nano J; van der Heijden AAWA; Willems van Dijk K; Slieker RC; Steyerberg EW; Ikram MA; Beekman M; Boomsma DI; van Duijn CM; Slagboom PE; Stehouwer CDA; Schalkwijk CG; Arts ICW; Dekker JM; Dehghan A; Muka T; van der Kallen CJH; Nijpels G; van Greevenbroek MMJ
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4569-4579. PubMed ID: 30113659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic signature shift in type 2 diabetes mellitus revealed by mass spectrometry-based metabolomics.
    Xu F; Tavintharan S; Sum CF; Woon K; Lim SC; Ong CN
    J Clin Endocrinol Metab; 2013 Jun; 98(6):E1060-5. PubMed ID: 23633210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term NO2 exposure is associated with long-chain fatty acids in prospective cohorts from Augsburg, Germany: results from an analysis of 138 metabolites and three exposures.
    Ward-Caviness CK; Breitner S; Wolf K; Cyrys J; Kastenmüller G; Wang-Sattler R; Schneider A; Peters A
    Int J Epidemiol; 2016 Oct; 45(5):1528-1538. PubMed ID: 27892410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomics - the complementary field in systems biology: a review on obesity and type 2 diabetes.
    Abu Bakar MH; Sarmidi MR; Cheng KK; Ali Khan A; Suan CL; Zaman Huri H; Yaakob H
    Mol Biosyst; 2015 Jul; 11(7):1742-74. PubMed ID: 25919044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic and proteomic signatures of hypoglycaemia in type 2 diabetes.
    Halama A; Kahal H; Bhagwat AM; Zierer J; Sathyapalan T; Graumann J; Suhre K; Atkin SL
    Diabetes Obes Metab; 2019 Apr; 21(4):909-919. PubMed ID: 30525282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of cultured myotubes and fasting plasma metabolite profiles with mitochondrial dysfunction in type 2 diabetes subjects.
    Abu Bakar MH; Sarmidi MR
    Mol Biosyst; 2017 Aug; 13(9):1838-1853. PubMed ID: 28726959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasting serum lipid and dehydroepiandrosterone sulfate as important metabolites for detecting isolated postchallenge diabetes: serum metabolomics via ultra-high-performance LC-MS.
    Liu L; Wang M; Yang X; Bi M; Na L; Niu Y; Li Y; Sun C
    Clin Chem; 2013 Sep; 59(9):1338-48. PubMed ID: 23620415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Untargeted serum metabolomics reveals Fu-Zhu-Jiang-Tang tablet and its optimal combination improve an impaired glucose and lipid metabolism in type II diabetic rats.
    Tao Y; Chen X; Cai H; Li W; Cai B; Chai C; Di L; Shi L; Hu L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():222-232. PubMed ID: 27866845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum metabolomics indicate altered cellular energy metabolism in children with cystic fibrosis.
    Joseloff E; Sha W; Bell SC; Wetmore DR; Lawton KA; Milburn MV; Ryals JA; Guo L; Muhlebach MS
    Pediatr Pulmonol; 2014 May; 49(5):463-72. PubMed ID: 23847148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomic analysis and biochemical changes in the urine and serum of streptozotocin-induced normal- and obese-diabetic rats.
    Mediani A; Abas F; Maulidiani M; Abu Bakar Sajak A; Khatib A; Tan CP; Ismail IS; Shaari K; Ismail A; Lajis NH
    J Physiol Biochem; 2018 Aug; 74(3):403-416. PubMed ID: 29766441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomics in Diabetes and Diabetic Complications: Insights from Epidemiological Studies.
    Jin Q; Ma RCW
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated biomarker for type 2 diabetes mellitus and impaired fasting glucose based on metabolomics analysis using ultra-high performance liquid chromatography quadrupole-Orbitrap high-resolution accurate mass spectrometry.
    Long J; Liu L; Jia Q; Yang Z; Sun Z; Yan C; Yan D
    Rapid Commun Mass Spectrom; 2020 Jun; 34(12):e8779. PubMed ID: 32159245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Untargeted metabolomic profiling reveals molecular signatures associated with type 2 diabetes in Nigerians.
    Doumatey AP; Shriner D; Zhou J; Lei L; Chen G; Oluwasola-Taiwo O; Nkem S; Ogundeji A; Adebamowo SN; Bentley AR; Gouveia MH; Meeks KAC; Adebamowo CA; Adeyemo AA; Rotimi CN
    Genome Med; 2024 Mar; 16(1):38. PubMed ID: 38444015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Profile of Individuals with and without Type 2 Diabetes from Sub-Saharan Africa.
    Skinner SC; Nemkov T; Diaw M; Mbaye MN; Diedhiou D; Sow D; Gueye F; Lopez P; Connes P; D'Alessandro A
    J Proteome Res; 2023 Jul; 22(7):2319-2326. PubMed ID: 37264938
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 27.